
ABUS vs PCRX
$ABUS vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABUS vs PCRX: the quick read
- ·ABUS is the larger company by market cap ($999M vs $993M).
- ·ABUS has been more active on our scanner (122 vs 28 alerts in 30 days).
- ·PCRX has the smaller float (34.1M vs 142.9M), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·ABUS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·ABUS draws far more of our scanner's attention, 122 unusual-volume alerts in 30 days against 28, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABUS and PCRX on TheDesperateTrader.
- Is ABUS or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. ABUS is the larger company by market cap ($999M vs $993M). ABUS has been more active on our scanner (122 vs 28 alerts in 30 days). PCRX has the smaller float (34.1M vs 142.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABUS and PCRX?
- The differences that matter: they are similar in size ($999M vs $993M); they trade at very different share prices ($5.07 vs $24.48); ABUS sits at 81% of its 52-week range against 64% for PCRX; our scanner flagged ABUS 122 times in the last 30 days against 28 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of ABUS and PCRX is more active right now?
- Right now ABUS is at about 0.7x its normal volume and PCRX is at about 0.6x, so ABUS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABUS or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABUS and PCRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.